FDA recall, , Moderate risk
American Health Packaging Metoclopramide Tablets
Metoclopramide Tablets may contain foreign tablets or capsules.
Summary by Recall Canary from the FDA notice
What happened
American Health Packaging, of Columbus, Ohio, recalled Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, because the product may contain foreign tablets or capsules. The recall, which began October 6, 2026, was added to the FDA's Enforcement Report on October 14, 2026, and affected 5,363 cartons distributed nationwide in the United States.
The product is described as Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, distributed by American Health Packaging. The recall was classified by the FDA on October 14, 2026, and listed in the agency's weekly enforcement report on October 21, 2026.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Affected if its NDC and lot code are listed under that product.
An NDC (National Drug Code) is usually printed on the drug's label.
Metoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only
- NDC
- 60687-620-01
- 60687-620-11
- Lot code
- 1028135
- 1029555
Recall details
- Company began the recall
- Sold in
US Nationwide
- Company
- American Health Packaging
- Hazard
- Foreign object
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 100100
- Recall number
- D-0042-2027
- Quantity recalled
- 5,363 cartons
All recalls from American Health Packaging
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
In FDA's weekly enforcement report
